U.S. market Open. Closes in 3 hours 47 minutes

INBX | Inhibrx, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for INBX we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is stunning wealthy, Growth is very bad and Health is very strong.

Valuation (43%)

Company Industry
P/E Ratio (TTM) 0.14 -23.05
PEG Ratio (TTM) 0.00 15.47
P/S Ratio (TTM) 120.07 49.46
P/B Ratio (TTM) 1.01 18.87
P/FCF Ratio (TTM) -0.93 -3.27
Price to 5YR AVG Earnings Ratio -5.02 -3.55
Price to 5YR AVG FCF Ratio -1.64 -9.37

Profitability (100%)

Company Industry
ROA (TTM) 632.27% -5.14%
ROE (TTM) 1,617.60% 16.69%
Net Profit Margin (TTM) 88,176.36% -1,583.93%
ROIC 5YR AVG 573.70% 15.15%

Growth (33%)

4QTR AVG 3YR AVG 5YR AVG
EPS 2,242.71% -22.79% -33.67%
Revenue 367.44% -23.14% 31.97%
Net Income 596.42% -25.87% -27.09%
Cash Flow -8.73% -14.52% -20.83%

Health (72%)

Company Industry
Current Ratio (TTM) 6.20 6.13
Quick Ratio (TTM) 6.20 5.85
D/E Ratio (TTM) 0.01 -15.81
Interest Coverage (TTM) -12.35 -1.57
Piotroski F-Score 2 5
Altman Z-Score 25.54 14.12
LTL to 5YR AVG FCF -1.52 0.17
Shares Outstanding Growth 5YR AVG -18.90% 123.44%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙